TCL Archive Advisors Approve $50 Million NCI Effort To Attack Cancer On a Molecular Level July 2, 1999
TCL Archive President’s Cancer Panel: NCI’s Approach “Paying Off,” Thompson Tells Cancer Panel June 1, 2001
TCL Archive FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment. September 28, 2001
TCL Archive IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed. April 16, 2010